A J Cumber - JoVE Visualize

Showing results (21-30 of 31) with videos related to

Pageof 4

Sort By:

European Journal of Biochemistry|March 1, 1980

Increased toxicity of diphtheria toxin for human lymphoblastoid cells following covalent linkage to anti-(human lymphocyte) globulin or its F(ab')2 fragmentW C Ross, P E Thorpe, A J Cumber, et al.

Bioconjugate Chemistry|September 1, 1992

Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxinsA J Cumber, J H Westwood, R V Henry, et al.

Blood|May 1, 1984

An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin AC D Myers, P E Thorpe, W C Ross, et al.

European Journal of Biochemistry|April 2, 1984

Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugatesP E Thorpe, W C Ross, A N Brown, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxinE J Wawrzynczak, G J Watson, A J Cumber, et al.

FEBS Letters|November 28, 1983

Ricin B chain converts a non-cytotoxic antibody-ricin A chain conjugate into a potent and specific cytotoxic agentD P McIntosh, D C Edwards, A J Cumber, et al.

British Journal of Cancer|August 1, 1992

Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancerE J Wawrzynczak, U Zangemeister-Wittke, R Waibel, et al.

Cancer Research|December 1, 1990

Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordinE J Wawrzynczak, A J Cumber, R V Henry, et al.

European Journal of Biochemistry|June 1, 1981

Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, geloninP E Thorpe, A N Brown, W C Ross, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1987

An ineffective monoclonal antibody-ricin A chain conjugate is converted to a tumouricidal agent in vivo by subsequent systemic administration of ricin B chainS A Eccles, D P McIntosh, H P Purvies, et al.

Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:

Pageof 4

European Journal of Biochemistry|March 1, 1980

Increased toxicity of diphtheria toxin for human lymphoblastoid cells following covalent linkage to anti-(human lymphocyte) globulin or its F(ab')2 fragmentW C Ross, P E Thorpe, A J Cumber, et al.

Bioconjugate Chemistry|September 1, 1992

Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxinsA J Cumber, J H Westwood, R V Henry, et al.

Blood|May 1, 1984

An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin AC D Myers, P E Thorpe, W C Ross, et al.

European Journal of Biochemistry|April 2, 1984

Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugatesP E Thorpe, W C Ross, A N Brown, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxinE J Wawrzynczak, G J Watson, A J Cumber, et al.

FEBS Letters|November 28, 1983

Ricin B chain converts a non-cytotoxic antibody-ricin A chain conjugate into a potent and specific cytotoxic agentD P McIntosh, D C Edwards, A J Cumber, et al.

British Journal of Cancer|August 1, 1992

Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancerE J Wawrzynczak, U Zangemeister-Wittke, R Waibel, et al.

Cancer Research|December 1, 1990

Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordinE J Wawrzynczak, A J Cumber, R V Henry, et al.

European Journal of Biochemistry|June 1, 1981

Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, geloninP E Thorpe, A N Brown, W C Ross, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1987

An ineffective monoclonal antibody-ricin A chain conjugate is converted to a tumouricidal agent in vivo by subsequent systemic administration of ricin B chainS A Eccles, D P McIntosh, H P Purvies, et al.

Pageof 4